Last Price$567.0(1.1%)
Market Cap$207.3B
LTM Enterprise Value
$183.3B
5Y avg
$102.2B
Medical - Instruments & Supplies industry
median
$825.7M
Stock quality & Intrinsic value
7/10
(0.8%) overvalued
Intuitive Surgical, Inc. Enterprise Value
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Enterprise Value | $4,011.2M | $3,348.9M | $12.1B | $4,428.0M | $10.4B | $7,827.2M | $15.7B | $18.0B | $11.7B | $16.3B | $16.6B | $18.8B | $35.9B | $47.3B | $65.6B | $91.2B | $125.7B | $88.8B | $112.3B | $183.3B |
Overvalued or undervalued?
Check the intrinsic value for ISRG
and see if it's the right time to invest.
Intuitive Surgical, Inc. (ISRG) Enterprise Value comparison analysis
General
LTM Enterprise Value
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Intuitive Surgical, Inc.ISRG
$203.3B
17.2%
27.7%
27.8%
Median Peer Set
$18.9B
1.7%
15.9%
10.2%
Becton, Dickinson and CompanyBDX
$84.0B
4.2%
18.3%
8.4%
Alcon Inc.ALC
$49.9B
8.5%
182.9%
10.3%
ResMed Inc.RMD
$35.0B
10.9%
13.4%
21.8%
Baxter International Inc.BAX
$29.6B
(69.5%)
(100.0%)
(6.9%)
The Cooper Companies, Inc.COO
$21.1B
8.4%
32.2%
10.1%
West Pharmaceutical Services, Inc.WST
$16.7B
(1.9%)
(15.5%)
17.0%
Hologic, Inc.HOLX
$12.8B
(0.0%)
81.1%
19.6%
Masimo CorporationMASI
$10.9B
0.6%
(42.5%)
4.0%
AptarGroup, Inc.ATR
$10.2B
2.7%
30.2%
10.5%
Repligen CorporationRGEN
$8,868.2M
(21.1%)
(80.9%)
5.6%
ISRG key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 227.3 63.8% | 372.7 63.9% | 600.8 61.2% | 874.9 45.6% | 1,052.2 20.3% | 1,413.0 34.3% | 1,757.3 24.4% | 2,178.8 24.0% | 2,265.1 4.0% | 2,131.7 (5.9%) | 2,384.4 11.9% | 2,704.4 13.4% | 3,128.9 15.7% | 3,724.2 19.0% | 4,478.5 20.3% | 4,358.4 (2.7%) | 5,710.1 31.0% | 6,222.2 9.0% | 7,124.1 14.5% | 8,352.1 17.2% |
| Cost of Goods Sold (COGS) | 73.8 | 124.8 | 186.5 | 254.1 | 301.1 | 383.0 | 483.5 | 608.5 | 670.9 | 717.9 | 806.5 | 814.3 | 934.8 | 1,120.1 | 1,368.3 | 1,497.2 | 1,751.6 | 2,026.2 | 2,394.6 | 2,717.9 |
% margin | 153.6 67.6% | 247.8 66.5% | 414.3 69.0% | 620.8 71.0% | 751.1 71.4% | 1,030.0 72.9% | 1,273.8 72.5% | 1,570.3 72.1% | 1,594.2 70.4% | 1,413.8 66.3% | 1,577.9 66.2% | 1,890.1 69.9% | 2,194.1 70.1% | 2,604.1 69.9% | 3,110.2 69.4% | 2,861.2 65.6% | 3,958.5 69.3% | 4,196.0 67.4% | 4,729.5 66.4% | 5,634.2 67.5% |
| Operating Expenses | 84.8 | 140.5 | 207.5 | 309.9 | 373.6 | 474.8 | 579.0 | 692.2 | 741.7 | 869.0 | 837.9 | 944.9 | 1,139.5 | 1,404.7 | 1,735.7 | 1,811.4 | 2,137.5 | 2,618.9 | 2,962.7 | 3,285.3 |
| Research & Development Expenses (R&D) | 17.4 | 29.8 | 48.9 | 79.4 | 95.1 | 116.0 | 140.2 | 170.0 | 167.7 | 178.0 | 197.4 | 239.6 | 328.6 | 418.1 | 557.3 | 595.1 | 671.0 | 879.0 | 998.8 | 1,145.3 |
| Selling, General & Administrative Expenses (SG&A) | 67.4 | 110.7 | 158.7 | 230.6 | 278.5 | 358.8 | 438.8 | 522.2 | 574.0 | 691.0 | 640.5 | 705.3 | 810.9 | 986.6 | 1,178.4 | 1,216.3 | 1,466.5 | 1,739.9 | 1,963.9 | 2,140.0 |
% margin | 68.8 30.3% | 107.4 28.8% | 206.7 34.4% | 310.8 35.5% | 377.4 35.9% | 555.2 39.3% | 694.8 39.5% | 878.1 40.3% | 852.5 37.6% | 544.8 25.6% | 740.0 31.0% | 945.2 35.0% | 1,054.6 33.7% | 1,199.4 32.2% | 1,374.5 30.7% | 773.6 17.7% | 1,821.0 31.9% | 1,211.3 19.5% | 1,766.8 24.8% | 2,348.9 28.1% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 116.8 | 157.2 | 69.3 | 29.7 | 192.1 | 324.9 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 15.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 29.7 | 0.0 | 0.0 |
| Pre-tax Income | 73.8 | 120.1 | 237.2 | 335.2 | 396.1 | 572.3 | 709.7 | 893.9 | 870.9 | 549.0 | 758.5 | 980.8 | 1,096.5 | 1,279.5 | 1,502.2 | 1,207.0 | 1,890.3 | 1,606.8 | 1,958.9 | 2,673.8 |
% effective tax rate | (20.3) (27.5%) | 48.1 40.0% | 92.7 39.1% | 130.9 39.0% | 163.5 41.3% | 190.5 33.3% | 214.6 30.2% | 237.3 26.5% | 199.9 23.0% | 130.2 23.7% | 169.7 22.4% | 244.9 25.0% | 436.5 39.8% | 154.5 12.1% | 120.4 8.0% | 140.2 11.6% | 162.2 8.6% | 262.4 16.3% | 141.6 7.2% | 336.3 12.6% |
% margin | 94.1 41.4% | 72.0 19.3% | 144.5 24.1% | 204.3 23.4% | 232.6 22.1% | 381.8 27.0% | 495.1 28.2% | 656.6 30.1% | 671.0 29.6% | 418.8 19.6% | 588.8 24.7% | 735.9 27.2% | 660.0 21.1% | 1,127.9 30.3% | 1,379.3 30.8% | 1,060.6 24.3% | 1,704.6 29.9% | 1,322.3 21.3% | 1,798.0 25.2% | 2,322.6 27.8% |
| EPS | 0.30 | 0.22 | 0.42 | 0.58 | 0.67 | 1.08 | 1.40 | 1.83 | 1.86 | 1.26 | 1.76 | 2.13 | 1.97 | 3.31 | 3.98 | 3.02 | 4.79 | 3.72 | 5.12 | 6.54 |
| Diluted EPS | 0.28 | 0.21 | 0.41 | 0.57 | 0.66 | 1.05 | 1.37 | 1.78 | 1.86 | 1.23 | 1.73 | 2.08 | 1.89 | 3.16 | 3.85 | 2.94 | 4.66 | 3.65 | 5.03 | 6.42 |
% margin | 75.5 33.2% | 107.4 28.8% | 219.8 36.6% | 335.9 38.4% | 377.4 35.9% | 595.6 42.2% | 741.3 42.2% | 935.9 43.0% | 919.8 40.6% | 619.2 29.0% | 740.0 31.0% | 1,050.7 38.9% | 1,157.9 37.0% | 1,322.2 35.5% | 1,374.5 30.7% | 1,049.8 24.1% | 1,821.0 31.9% | 1,577.1 25.3% | 2,169.0 30.4% | 2,673.8 32.0% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Intuitive Surgical, Inc.'s Enterprise Value?
As of today, Intuitive Surgical, Inc.'s last 12-month Enterprise Value is $183.3B, based on the financial report for Dec 30, 2024 (Q4’2024).
2) What is Intuitive Surgical, Inc.'s Enterprise Value growth rate?
Over the last year, Intuitive Surgical, Inc.'s Enterprise Value growth was 63.2%. The average annual Enterprise Value growth rates for Intuitive Surgical, Inc. have been 20.5% over the past three years, 22.8% over the past five years.
3) Is Intuitive Surgical, Inc.'s Enterprise Value growth rate Good?
Over the last year, Intuitive Surgical, Inc.'s Enterprise Value growth was 63.2%, which is higher than industry growth of 0.0%. It indicates that Intuitive Surgical, Inc.'s Enterprise Value growth is Good.